Literature DB >> 3458552

Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells.

R Kuzmits, P Aiginger, M M Müller, G Steurer, W Linkesch.   

Abstract

A short-term test in vitro is described, which can be used to detect resistance to cytostatic agents in leukaemic cells. Leukaemic cell suspensions were incubated with cytostatic agents and the resulting intracellular ATP concentrations were measured by a bioluminescence ATP assay. There was a clear dose-effect relationship in acute leukaemia and chronic lymphocytic leukaemia cells for drugs used in the treatment of leukaemias. A good correlation was found between the ATP content of leukaemic cells and cell viability as determined by the trypan blue dye exclusion test. Preliminary individual clinical correlations suggest a correlation between the chemosensitivity in vitro and the response patterns in vivo in leukaemia patients. This simple, fast and sensitive method may have application for determination of drug-induced cytotoxicity in leukaemic cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458552     DOI: 10.1042/cs0710081

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Evaluation of the effects of cosmetic or dermo-pharmaceutical products on cutaneous energy metabolism using the Episkin model of reconstructed epidermis.

Authors:  P Buche; L Violin; P Girard
Journal:  Cell Biol Toxicol       Date:  1994-12       Impact factor: 6.691

2.  Viability measurements of hybridoma cells in suspension cultures.

Authors:  J M Coco-Martin; J W Oberink; T A van der Velden-de Groot; E C Beuvery
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Suppression of primary breast, colon, gastric and bladder cancers cell growth in vitro by CKBM, a natural product.

Authors:  Wei Zhang; Edgar S L Liu; Jun Fu; Hai-Mei Tian; Ying-Jye Wu; Shiu-Fun Pang
Journal:  Invest New Drugs       Date:  2006-05       Impact factor: 3.651

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.